U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H21N3O5
Molecular Weight 467.4727
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of K252A

SMILES

COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)N3C4=C(C=CC=C4)C5=C3C6=C(C7=C(C=CC=C7)N26)C8=C5CNC8=O

InChI

InChIKey=KOZFSFOOLUUIGY-SOLYNIJKSA-N
InChI=1S/C27H21N3O5/c1-26-27(33,25(32)34-2)11-18(35-26)29-16-9-5-3-7-13(16)20-21-15(12-28-24(21)31)19-14-8-4-6-10-17(14)30(26)23(19)22(20)29/h3-10,18,33H,11-12H2,1-2H3,(H,28,31)/t18-,26+,27+/m1/s1

HIDE SMILES / InChI

Molecular Formula C27H21N3O5
Molecular Weight 467.4727
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

K-252a, a metabolite isolated from the culture broth of Nocardiopsis sp. K-252a, was found to exhibit an extremely potent inhibitory activity on protein kinase C. The IC50 value was 32.9 nM. K252a is a potent inhibitor of various protein kinases including Protein kinase A, Protein kinase C and Protein kinase G. It acts by competition with the ATP binding site with Ki values of 18-25 nM. K252a also acts as a specific and potent inhibitor (IC50 = 3 nM) of Trk receptors and thus selectively blocks the effects of nerve growth factor (NGF) on PC12 cells. At lower concentrations, K252a can act as a neuroprotective compound, promoting survival of primary neuronal cultures. This alkaloid induces apoptosis and cell cycle arrest by inhibiting Cdc2 and Cdc25.4 Recently, K252a was found to improve psoriasis in a SCID mouse-human skin model and to suppress referred mechanical hypersensitivity and neuropeptide up-regulation associated with acute pancreatitis.

CNS Activity

Curator's Comment: K252a does not cross the blood-brain barrier

Approval Year

PubMed

PubMed

TitleDatePubMed
K-252b, c and d, potent inhibitors of protein kinase C from microbial origin.
1986 Aug
Patents

Patents

Sample Use Guides

1.0 g K-252a (CT 327) cream will be applied to one target lesion twice daily
Route of Administration: Topical
In Vitro Use Guide
K-252a inhibited PMN PKC (IC50 = 0.58 uM), and caused a concentration-dependent (0.1-10 uM) inhibition of degranulation elicited with the chemotactic peptide, N-formyl-methionyl-leucyl-phenylalanine (FMLP), the lipid agonists, 5(S), 12(R)-dihydroxy-5,14-cis-8,10-trans eicosatetraenoic acid (LTB4) and acetyl-sn-glyceryl-3-phosphorylcholine (AGEPC), and phorbol 12-myristate 13-acetate.
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:42:45 GMT 2025
Edited
by admin
on Mon Mar 31 19:42:45 GMT 2025
Record UNII
IV7H45AM5B
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
K252A
Common Name English
K-252A
Preferred Name English
K 252A
Common Name English
(+)-SF 2370
Common Name English
9,12-EPOXY-1H-DIINDOLO(1,2,3-FG:3',2',1'-KL)PYRROLO(3,4-I)(1,6)BENZODIAZOCINE-10-CARBOXYLIC ACID, 2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-, METHYL ESTER, (9S-(9.ALPHA.,10.BETA.,12.ALPHA.))-
Common Name English
ANTIBIOTIC SF 2370
Common Name English
ANTIBIOTIC K 252A
Common Name English
PROTEIN KINASE INHIBITOR K252A
Common Name English
K 252
Common Name English
SF 2370
Common Name English
(+)-ANTIBIOTIC K 252A
Common Name English
(+)-K 252A
Common Name English
ANTIBIOTIC SF 2370, (+)-
Common Name English
ANTIBIOTIC K 252A, (+)-
Common Name English
(+)-ANTIBIOTIC SF 2370
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2089
Created by admin on Mon Mar 31 19:42:45 GMT 2025 , Edited by admin on Mon Mar 31 19:42:45 GMT 2025
Code System Code Type Description
WIKIPEDIA
K252A
Created by admin on Mon Mar 31 19:42:45 GMT 2025 , Edited by admin on Mon Mar 31 19:42:45 GMT 2025
PRIMARY
NCI_THESAURUS
C1382
Created by admin on Mon Mar 31 19:42:45 GMT 2025 , Edited by admin on Mon Mar 31 19:42:45 GMT 2025
PRIMARY
PUBCHEM
3035817
Created by admin on Mon Mar 31 19:42:45 GMT 2025 , Edited by admin on Mon Mar 31 19:42:45 GMT 2025
PRIMARY
DRUG BANK
DB02152
Created by admin on Mon Mar 31 19:42:45 GMT 2025 , Edited by admin on Mon Mar 31 19:42:45 GMT 2025
PRIMARY
FDA UNII
IV7H45AM5B
Created by admin on Mon Mar 31 19:42:45 GMT 2025 , Edited by admin on Mon Mar 31 19:42:45 GMT 2025
PRIMARY
EPA CompTox
DTXSID40880065
Created by admin on Mon Mar 31 19:42:45 GMT 2025 , Edited by admin on Mon Mar 31 19:42:45 GMT 2025
PRIMARY
CAS
99533-80-9
Created by admin on Mon Mar 31 19:42:45 GMT 2025 , Edited by admin on Mon Mar 31 19:42:45 GMT 2025
PRIMARY
CHEBI
43616
Created by admin on Mon Mar 31 19:42:45 GMT 2025 , Edited by admin on Mon Mar 31 19:42:45 GMT 2025
PRIMARY